Vedtofte, L., Bahne, E., Foghsgaard, S., Bagger, J. I., Andreasen, C., Strandberg, C., Gørtz, P. M., Holst, J. J.
, Grønbæk, H., Svare, J. A., Clausen, T. D., Mathiesen, E. R., Damm, P., Gluud, L. L., Knop, F. K. & Vilsbøll, T. (2020).
One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial.
Journal of Clinical Medicine,
9(10), 1-14. Article 3213.
https://doi.org/10.3390/jcm9103213